What Can Be Done About Peyronie's Disease

Two Phases, Two Different Approaches

Peyronie's disease moves through two distinct phases, and the right approach depends on which one someone is in. The active phase is when the curvature, the plaque beneath the skin, or any pain is still changing — usually worsening before it levels off. The stable phase begins once the curvature has stopped changing and any pain has resolved, and that's typically when more definitive treatments, including surgery, become worth considering.

This is a genital sore differential question as much as a Peyronie's one: a firm, non-tender lump felt along the shaft, without an open sore or blister, points toward Peyronie's disease, while an ulcer or blister points toward an infection such as genital herpes, which has no cure but is manageable with antiviral treatment 1Ref 1Centers for Disease Control and Prevention (2024).About Genital Herpes.Supports that genital herpes has no cure but is manageable with antiviral therapy and can occur without visible sores; used to differentiate an open sore or blister (infection) from the firm, non-ulcerated lump characteristic of Peyronie's disease.. For what a curved, painful erection actually looks and feels like day to day, and how it's usually first recognized, a companion piece covers the symptom side in more depth; this one focuses on what happens next.

There's no simple test that marks the exact moment one phase ends and the other begins — clinicians generally track symptoms over a run of appointments, watching for the curvature and pain to stop changing, rather than picking a fixed calendar date. Treating too early, before the plaque has stabilized, risks the deformity changing again after a fix; waiting too long through a painful active phase means unnecessary discomfort. That trade-off is why the two phases lead to genuinely different care plans rather than one fixed protocol.

The Active Phase: What Helps While It's Still Changing

During the active phase, many clinicians favor watching and waiting over aggressive intervention, since the plaque is still evolving and some early treatments can be revisited once things settle. Oral and topical treatments have been tried for decades with inconsistent results, and injected medication is sometimes started earlier than surgery would ever be considered.

This is also the phase where pain, when present, tends to be most bothersome — pain from Peyronie's disease usually eases as the plaque stabilizes, even before the curvature itself does. Because the deformity is still moving, this phase is generally not the time for a surgical fix: operating on a curve that hasn't finished changing risks having to revisit it later. What's reasonable during this window is a conversation about symptom management and, for some people, starting one of the non-surgical treatments described below.

Injectable Treatment: Targeting the Scar Tissue Directly

For curvature that has stabilized and is significant enough to interfere with sex, an injectable medication can be delivered directly into the fibrous plaque across a series of office visits, with the goal of breaking down enough of the built-up collagen to reduce the curve. Stretching exercises are typically paired with the injections to help the tissue remodel as it softens.

The plaque in Peyronie's disease is the band of scar tissue inside the penis that causes it to bend toward the affected side during an erection; the injectable approach works by breaking down collagen within that specific plaque rather than affecting the surrounding tissue. It's typically reserved for the stable phase and for curvature significant enough — usually because it's affecting intercourse — to justify a multi-visit course of treatment rather than a single fix. Bruising and swelling after each injection are common and expected as the tissue responds.

Traction and Vacuum Therapy

Mechanical traction devices apply gentle, sustained stretching force to the penis over weeks to months, with the goal of gradually remodeling the plaque and improving both curvature and any loss of length. They're sometimes used on their own and sometimes alongside injectable treatment, worn for a period of time each day.

Consistency matters more than intensity with traction — the tissue responds to sustained, gentle stretch over time, not to a single aggressive session. It's a slower, more self-directed option than injections or surgery, which makes it appealing to some people and impractical for others depending on how the daily time commitment fits their life. It's generally considered lower-risk than injectable or surgical treatment, which is part of why some clinicians suggest starting there during the transition from the active to the stable phase.

When Surgery Is the Right Call

Surgery is generally reserved for the stable phase and for curvature severe enough to prevent comfortable intercourse, especially after non-surgical options haven't resolved it. The specific procedure depends on the degree of curvature, penile length, and whether erectile function is also affected, and falls into three general categories.

• Plication: shortens the longer, unaffected side to match the shorter, scarred side — generally suited to modest curvature, with a lower complication rate but a small resulting length loss.
• Incision or grafting: lengthens the shorter, scarred side using a graft — better suited to more severe curvature, but carries a higher chance of new or worsened erectile dysfunction afterward.
• Penile implant: considered when significant erectile dysfunction already coexists with the curvature, addressing both issues in one procedure.

The choice among these is a detailed conversation with a urologist about degree of curvature, prior treatments tried, and priorities around length, function, and recovery — there isn't a single 'best' option that applies across cases.

Peyronie's and Erectile Dysfunction Often Travel Together

Erectile dysfunction shows up in a substantial share of people with Peyronie's disease, and the overlap isn't coincidental: both conditions involve the blood vessels and tissue of the penis, and ED itself is often a marker of vascular health rather than a problem confined to one organ. This connects Peyronie's disease to erectile dysfunction cardiovascular risk more broadly than the curvature alone might suggest.

Erectile dysfunction and cardiovascular disease share an underlying mechanism in the blood vessel lining — endothelial dysfunction — and ED can be an early marker of cardiovascular risk that shows up before other symptoms do 2Ref 2Gandaglia G, Briganti A, Jackson G, et al. (2014).A systematic review of the association between erectile dysfunction and cardiovascular disease.Supports that erectile dysfunction and cardiovascular disease share an endothelial-dysfunction mechanism and that ED can be an early marker of cardiovascular risk; used to explain why Peyronie's evaluations often screen for ED and cardiovascular health together.. That's part of why a Peyronie's evaluation often includes questions about erectile function and general cardiovascular health, not just the curvature itself. Treating the two together, when both are present, tends to give a fuller picture than treating the curve in isolation, and can flag a cardiovascular conversation that might not otherwise have come up.

A Practical Note: Who Sees the Claim

Treatment for Peyronie's disease, like most medical care, generates an insurance claim, and for anyone on a spouse's or a parent's health plan, that claim can show up on an explanation of benefits the policyholder receives — a real privacy consideration for people who'd rather keep this private.

Under HIPAA, a health plan is generally permitted to send that kind of billing information to the policyholder as part of normal payment operations 3Ref 3U.S. Department of Health and Human Services, Office for Civil Rights (2013).Uses and Disclosures for Treatment, Payment, and Health Care Operations.Supports that HIPAA permits a health plan to disclose treatment and billing information to the policyholder as part of payment operations without separate patient authorization; used to explain that a dependent's Peyronie's treatment claim may appear on a policyholder's EOB, and that a confidential communications request can address this., and the sender doesn't need the patient's separate permission to do so. For anyone concerned about this, most insurers and clinics can process a confidential communications request — asking that statements go directly to the patient rather than the primary policyholder — though the request has to be made proactively rather than assumed.